ProfileGDS4718 / 237206_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 32% 34% 98% 31% 48% 28% 27% 34% 53% 46% 38% 36% 24% 28% 25% 77% 45% 32% 25% 38% 61% 46% 42% 52% 59% 31% 56% 28% 34% 27% 23% 84% 31% 25% 51% 32% 27% 31% 28% 98% 47% 29% 73% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6510832
GSM549102patient 115, normal, homogenized [OPG study]4.7394334
GSM549104patient 119, normal, homogenized [OPG study]11.814698
GSM549108patient 138, normal, homogenized [OPG study]4.6225131
GSM549119patient 077, normal, homogenized [OPG study]5.4189748
GSM549133patient 032, cancer, homogenized [OPG study]4.3916728
GSM549139patient 042, cancer, homogenized [OPG study]4.3993327
GSM549099patient 107, normal, homogenized [OPG study]4.7365734
GSM549109patient 139, normal, homogenized [OPG study]5.6917653
GSM549110patient 046, normal, homogenized [OPG study]5.3008546
GSM549114patient 063, normal, homogenized [OPG study]4.8525338
GSM549122patient 082, normal, homogenized [OPG study]4.8059536
GSM549134patient 033, cancer, homogenized [OPG study]4.2972824
GSM549136patient 036, cancer, homogenized [OPG study]4.3958928
GSM549140patient 044, cancer, homogenized [OPG study]4.3054325
GSM549111patient 047, normal, homogenized [OPG study]7.5352277
GSM549113patient 057, normal, homogenized [OPG study]5.1613545
GSM549132patient 031, cancer, homogenized [OPG study]4.6192232
GSM549137patient 038, cancer, homogenized [OPG study]4.3100625
GSM549142patient 047, cancer, homogenized [OPG study]5.0281938
GSM549100patient 110, normal, homogenized [OPG study]6.1685861
GSM549107patient 135, normal, homogenized [OPG study]5.2587746
GSM549115patient 068, normal, homogenized [OPG study]5.0469742
GSM549116patient 072, normal, homogenized [OPG study]5.6096752
GSM549120patient 078, normal, homogenized [OPG study]6.0368459
GSM549131patient 030, cancer, homogenized [OPG study]4.5159631
GSM549118patient 074, normal, homogenized [OPG study]5.8916456
GSM549129patient 027, cancer, homogenized [OPG study]4.4646228
GSM549123patient 088, normal, homogenized [OPG study]4.7078634
GSM549124patient 006, cancer, homogenized [OPG study]4.4697427
GSM549126patient 015, cancer, homogenized [OPG study]4.2523623
GSM549128patient 025, cancer, homogenized [OPG study]8.3910384
GSM549103patient 117, normal, homogenized [OPG study]4.6278631
GSM549117patient 073, normal, homogenized [OPG study]4.2972825
GSM549138patient 041, cancer, homogenized [OPG study]5.5857651
GSM549141patient 045, cancer, homogenized [OPG study]4.5650132
GSM549130patient 028, cancer, homogenized [OPG study]4.4166227
GSM549101patient 111, normal, homogenized [OPG study]4.6270331
GSM549105patient 128, normal, homogenized [OPG study]4.4820228
GSM549106patient 134, normal, homogenized [OPG study]11.450698
GSM549112patient 048, normal, homogenized [OPG study]5.3192747
GSM549125patient 011, cancer, homogenized [OPG study]4.5227429
GSM549127patient 024, cancer, homogenized [OPG study]7.2183773
GSM549135patient 035, cancer, homogenized [OPG study]4.7186235